Moxifloxacin: Physical-chemical and Microbiological Analytical Methods in the Context of Green Analytical Chemistry.

Moxifloxacin analytical methods biological matrices fluoroquinolone green analytical chemistry pharmaceutical

Journal

Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487

Informations de publication

Date de publication:
06 Jun 2023
Historique:
received: 12 12 2022
accepted: 13 02 2023
medline: 12 6 2023
pubmed: 16 5 2023
entrez: 16 5 2023
Statut: ppublish

Résumé

Moxifloxacin (MOX) is a fourth-generation fluoroquinolone used in the form of tablets, infusion solutions and ophthalmic solutions. It does not have a physical-chemical or microbiological analytical method described in an official compendium. However, the literature shows some analysis methods for pharmaceuticals and biological matrices. In this context, the objective is to show the analytical methods present in the literature for the investigation of MOX by physical-chemical and microbiological techniques, as well as discussing them according to the requirements of current pharmaceutical analyses and green analytical chemistry. Among the physical-chemical methods present in the literature for MOX evaluation, 33% are HPLC, 21% are UV-Vis and 17% are capillary electrophoresis. On the other hand, among the microbiological methods, all of them are based on diffusion in agar. There is still scope in the literature to incorporate new and improved analytical methods for MOX evaluation, which adopt the concepts of green and sustainable analytical chemistry, either by using less (or not using) toxic organic solvents, reducing waste generation or even reducing the analysis time according to the intended objectives.

Identifiants

pubmed: 37190804
pii: CPD-EPUB-131794
doi: 10.2174/1381612829666230515150730
doi:

Substances chimiques

Moxifloxacin U188XYD42P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1166-1172

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Thaisa Alves Celedonio da Silva (TAC)

Department of Pharmacy, Faculty of Pharmacy, Federal University of Goiás, Goiânia, Brazil.

Isadora Alves Lustosa (IA)

Department of Pharmacy, Faculty of Pharmacy, Federal University of Goiás, Goiânia, Brazil.

Ana Carolina Kogawa (AC)

Department of Pharmacy, Faculty of Pharmacy, Federal University of Goiás, Goiânia, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH